Sept 20 (Reuters) - Universal Biosensors Inc (UBI) :
- EXTENDS CLINICAL DEVELOPMENT TRIALS FOR TN ANTIGEN CANCER BIOSENSOR
News: UBI Universal Biosensors Says Extends Clinical Development Trials For TN Antigen Cancer...
Add to My Watchlist
What is My Watchlist?